DrugPatentWatch Database Preview
Drugs in Development Information for Amylamine
Email this page to a colleague
» See Plans and PricingWhat is the development status for investigational drug Amylamine?
Amylamine is an investigational drug.
There have been 19 clinical trials for Amylamine.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 18th 2019.
The most common disease conditions in clinical trials are Depressive Disorder, Depression, and Depressive Disorder, Major. The leading clinical trial sponsors are Yale University, Targacept Inc., and CoMentis.
There are two US patents protecting this investigational drug and twenty-seven international patents.
Summary for Amylamine
| US Patents | 2,788 |
| International Patents | 27,732 |
| US Patent Applications | 4,448 |
| WIPO Patent Applications | 1,762 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2019-04-18) |
| Vendors | 46 |
Recent Clinical Trials for Amylamine
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis | Atacama Therapeutics | Phase 2 |
| Pilot Study of Mecamylamine for Autonomic Dysreflexia Prophylaxis | Wayne State University | Phase 4 |
| Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis | Atacama Therapeutics | Phase 2 |
Clinical Trial Summary for Amylamine
Top disease conditions for Amylamine
Top clinical trial sponsors for Amylamine
US Patents for Amylamine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Amylamine | Start Trial | Process for protecting bearings in steel mills and other metal processing mills | Amoco Corporation (Chicago, IL) | Start Trial |
| Amylamine | Start Trial | Preparation of organometallic amide compositions | Lithium Corporation of America (Gastonia, NC) | Start Trial |
| Amylamine | Start Trial | Process for obtaining ceric oxide | Rhone-Poulenc Chimie (Courbevoie, FR) | Start Trial |
| Amylamine | Start Trial | Catalyst for the amination of alcohols under hydrogenating conditions | BASF Aktiengesellschaft (Ludwigshafen, DE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Amylamine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Amylamine | Canada | 1282402 | 2006-02-18 | Start Trial |
| Amylamine | Canada | 1297862 | 2006-02-18 | Start Trial |
| Amylamine | Canada | 2010924 | 2006-02-18 | Start Trial |
| Amylamine | Canada | 2074308 | 2006-02-18 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
